VIR
NASDAQ · Biotechnology
Vir Biotechnology Inc
$8.57
-0.27 (-3.05%)
Open$8.75
Previous Close$8.84
Day High$8.77
Day Low$8.51
52W High$9.97
52W Low$4.16
Volume—
Avg Volume1.54M
Market Cap1.00B
P/E Ratio—
EPS$-3.62
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+98.1% upside
Current
$8.57
$8.57
Target
$16.98
$16.98
$13.41
$16.98 avg
$22.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 71.78M | 176.09M | 113.39M |
| Net Income | -504,907,326 | -1,114,859,159 | -30,823,495 |
| Profit Margin | -703.4% | -668.2% | -27.2% |
| EBITDA | -569,842,810 | -1,328,141,976 | -42,153,177 |
| Free Cash Flow | — | — | -22,930,380 |
| Rev Growth | -59.2% | -59.2% | +24.3% |
| Debt/Equity | — | — | 0.94 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |